B
BeOne Medicines
Innovative oncology therapeutics for global cancer care accessibility, formerly BeiGene
At a glance
- Status
- Listed
- Listing
- IPO 2016
Open roles
BeOne Medicines in the Dongcheng District ecosystem
The BeOne Medicines office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Hillhouse Capital- CCCITIC Capital
Series B and later1 investor entered at this stage
- RCRock Springs Capital
Source: Dealroom Talent Intelligence.
Alumni founders
Former BeOne Medicines employees who went on to found companies, sorted by Dealroom signal score.
DBD3 BioEst. 2020
George ChenChina
Ling WuSingapore
INInxMedEst. 2018
Francis CaoChina
PHPi HealthEst. 2023Patents
433 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where BeOne Medicines was the backer or acquirer, 2021–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across BeOne Medicines's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where BeOne Medicines deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
BeOne Medicines's portfolio, mapped.
See BeOne Medicines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
BeOne wins FDA approval for Tevimbra-based combo in first-line HER2+ stomach & oesophageal cancer

